Direkt zum Inhalt
Merck

Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer.

Developmental cell (2020-02-26)
Anand Vasudevan, Prasamit S Baruah, Joan C Smith, Zihua Wang, Nicole M Sayles, Peter Andrews, Jude Kendall, Justin Leu, Narendra Kumar Chunduri, Dan Levy, Michael Wigler, Zuzana Storchová, Jason M Sheltzer
ZUSAMMENFASSUNG

High levels of cancer aneuploidy are frequently associated with poor prognosis. To examine the relationship between aneuploidy and cancer progression, we analyzed a series of congenic cell lines that harbor single extra chromosomes. We found that across 13 different trisomic cell lines, 12 trisomies suppressed invasiveness or were largely neutral, while a single trisomy increased metastatic behavior by triggering a partial epithelial-mesenchymal transition. In contrast, we discovered that chromosomal instability activates cGAS/STING signaling but strongly suppresses invasiveness. By analyzing patient copy-number data, we demonstrate that specific aneuploidies are associated with distinct outcomes, and the acquisition of certain aneuploidies is in fact linked with a favorable prognosis. Thus, aneuploidy is not a uniform driver of malignancy, and different aneuploidies can uniquely influence tumor progression. At the same time, the gain of a single chromosome is capable of inducing a profound cell state transition, thereby linking genomic plasticity, phenotypic plasticity, and metastasis.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
Anti-α-Tubulin-Antikörper, monoklonaler Antikörper der Maus gegen, clone DM1A, purified from hybridoma cell culture
Sigma-Aldrich
Anti-MB21D1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
AZ3146, ≥98% (HPLC)